Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China
· Delayed Price · Currency is CNY 27.95
-0.44 (-1.55%)
Mar 9, 2026, 4:00 PM EDT
SHA:603207 Revenue
Shanghai Xiao Fang Pharmaceutical had revenue of 127.43M CNY in the quarter ending September 30, 2025, with 20.87% growth. This brings the company's revenue in the last twelve months to 504.59M, up 6.89% year-over-year. In the year 2024, Shanghai Xiao Fang Pharmaceutical had annual revenue of 474.58M with 0.57% growth.
Revenue (ttm)
504.59M
Revenue Growth
+6.89%
P/S Ratio
9.00
Revenue / Employee
1.25M
Employees
404
Market Cap
4.54B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| Jinhe Biotechnology CO., LTD. | 2.75B |
| Jinling Pharmaceutical Company | 3.13B |
| Shanghai Jiaoda Onlly Co.,Ltd | 312.75M |
| Yabao Pharmaceutical Group | 2.27B |
| Sinotherapeutics | 446.50M |
| Tibet Weixinkang Medicine | 1.17B |
| LanZhou Foci Pharmaceutical | 895.75M |